Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases

NCT07022197 is registered in ClinicalTrials.gov with Tianjin Medical University General Hospital as lead sponsor.

NCT NCT07022197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07022197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Lead sponsor
Tianjin Medical University General Hospital
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 10, 2025
Completion date
December 30, 2027
Enrollment
27 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic inflammatory demyelinating polyradiculoneuropathy, idiopathic inflammatory myopathies, myasthenia gravis, nmo spectrum disorder